Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Febuxostat Extended Release tablets bulk supplier for pharma manufacturers

Febuxostat Extended Release Tablets 80mg Suppliers & Bulk Manufacturers

Available Forms: tablets

Available Strengths: 80mg

Reference Brands: Adenuric (EU/UK)

Category: Nephrology

Febuxostat is an oral xanthine-oxidase inhibitor indicated for long-term management of hyperuricaemia in patients with gout who require urate-lowering therapy. It is prescribed when allopurinol is unsuitable or not tolerated.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Febuxostat Extended Release Tablets — third party manufacturing & bulk supply

Febuxostat Extended Release Tablets 80mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Febuxostat Extended Release Tablets is supplied as tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Febuxostat Extended Release Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Febuxostat Extended Release Tablets →
Back to Listing

Frequently Asked Questions

Febuxostat is used to lower uric acid levels in the blood and prevent gout attacks in adults. Gout occurs when there is a buildup of uric acid crystals in the joints, leading to inflammation and pain. Febuxostat helps by inhibiting the enzyme xanthine oxidase, which is responsible for producing uric acid, thereby reducing its levels and preventing crystal formation.

Febuxostat is made from the active ingredient febuxostat, a non-purine selective xanthine oxidase inhibitor. Its chemical composition is 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid, along with inactive ingredients such as lactose monohydrate, microcrystalline cellulose, and magnesium stearate (depending on the formulation).

The most common trade names of Febuxostat are

Febuxostat (Uloric) is manufactured by

The generic name of the drug is

Brand names include

Febuxostat is manufactured in multiple regions, including

Related Products

Lactitol Monohydrate Powder

Strength:
10 Gm sachets.

Form: powder

Reference Brands:

View Details
Ferric Citrate Tablets

Strength:
1.1gm Tablets Equivalent to 210mg Elemental Iron

Form: tablets

Reference Brands: Auryxia (US)

View Details
Probiotic Capsules

Strength:
-

Form: Capsules

Reference Brands:

View Details
Tri Sodium Citrate Catheter Locking Solution

Strength:
5ml

Form: solution

Reference Brands:

View Details
Cinacalcet Hydrochloride

Strength:
30 mg 60 mg 90 mg

Form: Tablet

Reference Brands: Sensipar,Cinacalcet (EU & US)

View Details
Ferric Citrate

Strength:
210 mg

Form: Tablet

Reference Brands: Auryxia (US & EU)

View Details
Lanthanum Carbonate

Strength:
500 mg 750 mg 1,000 mg

Form: Tablet

Reference Brands: Fosrenol (US & EU)

View Details
Prolonged-Release Potassium Chloride Generics

Strength:
8 mEq (600 mg), 10 mEq (750 mg), 15mEq (1,125 mg), 20mEq (1,500 mg)

Form: Tablet

Reference Brands: Klor-Con®, K-Dur®, K-Tab®, Micro-K® (US), KCl Retard®, Kaleorid®, Kalium-Retard®, Slow-K® (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.